A Prospective, Open-Label Trial of Clevidipine for Controlled Hypotension During Posterior Spinal Fusion

OBJECTIVES: Controlled hypotension is one means to limit or avoid the need for allogeneic blood products. Clevidipine is a short-acting, intravenous calcium channel antagonist with a half-life of 1 to 3 minutes due to rapid metabolism by non-specific blood and tissue esterases. To date, there are no...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pediatr Pharmacol Ther
Autors principals: Kako, Hiromi, Gable, Andrew, Martin, David, Beebe, Allan, Thung, Arlyne, Samora, Walter, Klamar, Jan, Bhalla, Tarun, Tobias, Joseph D.
Format: Artigo
Idioma:Inglês
Publicat: Pediatric Pharmacy Advocacy Group 2015
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353201/
https://ncbi.nlm.nih.gov/pubmed/25859171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-20.1.54
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars